Tuesday, November 03, 2015 11:48:49 AM
Here is my take on where we are for both drugs.
Alferon - not much to do here. The company is currently fully staffed and validating batch runs for an FDA inspection early next year.
Ampligen - there is some here, IMO.
The NIH has now promised to commit resources to ME/CFS
http://news.sciencemag.org/health/2015/10/nih-refocuses-research-chronic-fatigue-syndrome
This is a big deal. It has taken 30 years. The political winds are finally shifting with regard to this disease. How does this jive with ampligen?
The experts letter, pinned to the top of this forum, lays it out. As Carter said in the webcast, Hemispherx is "the last man standing' with regard to effective treatmentsfor at least a portion of CFS patients. (Rituximab trials in Norway are a long way from approval in the USA)
The FDA has approved ampligen for export to the European Union, Turkey, Austria, New Zealand. Maybe someone can find another unapproved drug, that meets the requirements of both the sending and receiving countries.... that qualifies it for export, for expanded patient access??
http://hemispherx.com/content/investor/default.asp?goto=833
http://hemispherx.com/content/investor/default.asp?goto=834
IMO, the FDA would not allow expanded access for these other countries, if they did not also have a plan for expanded access for the USA. All hell would break loose.
Hemispherx recently backed off on their price hike. Delayed until the end of March - which gives someone a 6 month window to get something done. With a record of a 17 YEAR treatment IND, it is difficult to imagine there is not a presumption of efficacy by the FDA. Otherwise they would have killed the Amp511 trial.
http://hemispherx.com/content/investor/default.asp?goto=847
Hemispherx spent a million dollars the past 18 months looking for a sub-group and a bio-marker. A bio-marker they can tie to improvements with ampligen. They think they've found such a biomarker.
http://hemispherx.com/content/investor/default.asp?goto=846
Maybe this period is just the calm before the storm??? :)
Recent HEB News
- TMX Group Equity Financing Statistics - April 2023 • PR Newswire (Canada) • 05/08/2023 01:00:00 PM
- Statistiques de financement par actions du Groupe TMX pour avril 2023 • PR Newswire (Canada) • 05/08/2023 01:00:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM